OncoDecipher vs Promise Bio
OncoDecipher vs Promise Bio, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: OncoDecipher is on 43/100 and Promise Bio on 53/100.
Where each one leads
OncoDecipher
Leads on none of the measures we hold for both companies.
Promise Bio
- our overall score: 53/100 against 43/100
- funding raised: $9.8M against $1.0M
At a glance
| Measure | OncoDecipher | Promise Bio |
|---|---|---|
| What it is | OncoDecipher uses silent mutations in cancer genomes to predict cancer type and survival probability. | AI-powered epiproteomic analysis platform for mass spectrometry data. |
| Category | Life Sciences, Cancer, Oncology, Mutation | Life Sciences, Biotech, Proteomics, HealthTech |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2015 | 2022 |
| Headquarters | Cambridge, United States | San Francisco, United States |
| Status | Inactive | Inactive |
Size, funding and growth
| Measure | OncoDecipher | Promise Bio |
|---|---|---|
| Employees | Not published | 14 |
| Total funding | $1.0M | $9.8M |
| Latest round | Seed | Seed |
| LinkedIn followers | Not published | 1,451 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | OncoDecipher | Promise Bio |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 43/100 | 53/100 |
| Traction | 30/100 | 47/100 |
| Team | 60/100 | 60/100 |
| Search visibility | 3/100 | 33/100 |
| Quality | 52/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | Not published | F (21/100) |
| Domain ratingLink authority, 0-100 | Not published | 2/100 |
OncoDecipher vs Promise Bio: common questions
Which is better, OncoDecipher or Promise Bio?
On our 0-100 score Promise Bio rates higher (53/100 against 43/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do OncoDecipher and Promise Bio compare on the numbers?
Promise Bio leads on our overall score (53/100 against 43/100), funding raised ($9.8M against $1.0M).
Read the full OncoDecipher review and pricing or the Promise Bio review and pricing. You can also browse other OncoDecipher alternatives we track.